Tuldrà A, Fumaz C R, Ferrer M J, Bayés R, Arnó A, Balagué M, Bonjoch A, Jou A, Negredo E, Paredes R, Ruiz L, Romeu J, Sirera G, Tural C, Burger D, Clotet B
HIV Unit, "Fundació Lluita SIDA" and "IrsiCaixa" Retrovirology Laboratory, "Germans Trias i Pujol" University Hospital, Badalona, Spain.
J Acquir Immune Defic Syndr. 2000 Nov 1;25(3):221-8. doi: 10.1097/00126334-200011010-00003.
Nearly perfect compliance seems to be indispensable to obtain the maximum benefit from highly active antiretroviral therapy (HAART). Interventions to ensure a high level of adherence during a relatively long-term period of therapy are necessary.
This is a prospective, randomized, two-arm controlled study including patients starting their first-or second-line HAART who were randomized to receive psychoeducative intervention to implement adherence (experimental group [EG]) or a usual medical follow-up (control group [CG]). We aimed to study the efficacy of a psychoeducative intervention to ensure long-term adherence to HAART, its relation with the virologic efficacy of treatment, and to determine the variables related to long-term adherence. Visits were made at weeks 0, 4, 24, and 48 for data collection. Self-reported adherence was registered at each visit and its veracity was tested by randomized blood analyses performed without previous warning to 40% of patients. Appropriate adherence was defined as the consumption of >/=95% of medication prescribed. Statistical analyses were performed both by the as treated (AT) and the intention to treat missing = failure (ITT) methods.
In all, 116 patients were included. At week 48, 94% of patients in the EG versus 69% controls achieved adherence >/=95% (p =.008); 89% of patients in the EG versus 66% controls had HIV-1 RNA levels <400 copies/ml (p =.026). Overall, 85% of patients with adherence >/=95% but only 45% of those with adherence <95% had viral load (VL) <400 copies/ml (p =. 008). In multivariate analysis, variables significantly related to adherence were having received a psychoeducative intervention (odds ratio [OR], 6.58; p =.04), poor effort to take medication (OR, 5.38; p =.03), and high self-perceived capacity to follow the regimen (OR, 13.76; p =.04). Self-reported adherence and drug plasma levels coincided in 93% of cases. However, differences in adherence did not reach statistical significance in the ITT analysis although a clear tendency toward benefit was observed in EG.
Specific and maintained psychoeducative interventions based on excellence on clinical practice are useful to keep high levels of adherence as well as high levels of viral suppression. There is a clear relation between high adherence levels and virologic success. Assessment of certain specific variables related to adherence may be helpful to monitor patient's compliance in the clinical setting.
近乎完美的依从性似乎是从高效抗逆转录病毒疗法(HAART)中获得最大益处所不可或缺的。有必要采取干预措施以确保在相对长期的治疗期间保持较高的依从性。
这是一项前瞻性、随机、双臂对照研究,纳入开始接受一线或二线HAART治疗的患者,他们被随机分为接受心理教育干预以促进依从性的组(实验组[EG])或常规医疗随访组(对照组[CG])。我们旨在研究心理教育干预对确保长期坚持HAART的疗效、其与治疗的病毒学疗效的关系,并确定与长期依从性相关的变量。在第0、4、24和48周进行访视以收集数据。每次访视时记录自我报告的依从性,并通过对40%的患者进行无预先通知的随机血液分析来检验其准确性。适当的依从性定义为服用规定药物的比例≥95%。采用治疗后(AT)和意向性分析(ITT,缺失=失败)方法进行统计分析。
总共纳入了116名患者。在第48周时,实验组94%的患者实现了依从性≥95%,而对照组为69%(p = 0.008);实验组89%的患者HIV-1 RNA水平<400拷贝/ml,而对照组为66%(p = 0.026)。总体而言,依从性≥95%的患者中有85%的病毒载量(VL)<400拷贝/ml,而依从性<95%的患者中只有45%(p = 0.008)。在多变量分析中,与依从性显著相关的变量包括接受了心理教育干预(优势比[OR],6.58;p = 0.04)、服药努力程度差(OR,5.38;p = 0.03)以及自我感觉遵循治疗方案的能力高(OR,13.76;p = 0.04)。自我报告的依从性与药物血浆水平在93%的病例中相符。然而在ITT分析中,依从性的差异未达到统计学显著意义,尽管在实验组中观察到了明显的受益趋势。
基于卓越临床实践的特定且持续的心理教育干预有助于保持高水平的依从性以及高水平的病毒抑制。高依从性水平与病毒学成功之间存在明确关系。评估某些与依从性相关的特定变量可能有助于在临床环境中监测患者的依从性。